高级检索
当前位置: 首页 > 详情页

Over-expression of microRNA-25 promotes cell proliferation and induces cell apoptosis in patients with hepatocellular carcinoma

| 导出 |

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Affiliated Hosp Hebei Univ, Dept Hepatobiliary Surg, Baoding 071000, Hebei Province, Peoples R China [2]Three Gorges Univ Peoples Hosp, Peoples Hosp Yichang 1, Dept Gen Surg, Yichang, Hubei Province, Peoples R China
出处:
ISSN:

关键词: Hepatocellular carcinoma miR-25 proliferation apoptosis prognosis

摘要:
Backgrounds: microRNAs (miRNAs) have been confirmed to play an important role in the occurrence and development of cancers. The purpose of this study was to investigate the effects of miR-25 on the cell growth of HCC and its prognostic role. Methods: The expression of miR-25 was detected by quantitative real-time reverse transcriptase-polymerase chain reaction (qRT-PCR) analysis. The relationship between miR-25 expression and clinical factors was also analyzed. The proliferation and apoptosis assay were conducted to compare the influences of miR-25 expression on cell growth. Kaplan-Meier analysis was used to evaluate the overall survival of patients with different miR-25 expression. The prognostic value was estimated via Cox regression analysis. Results: miR-25 was over-expression in HCC tissues compared to adjacent normal tissues. And its expression was influenced by AFP significantly. The cell proliferation of HCC cells was promoted by miR-25 while the apoptosis of it was inhibited. Patients with high miR-25 expression had a shorter overall survival than those with low expression through Kaplan-Meier analysis. Cox regression analysis showed high expression of miR-25 was closely related to the prognosis of HCC. Conclusions: miR-25 was increased in HCC patients and it could promote cell proliferation as well as suppress cell apoptosis. Moreover, it might serve as an independent marker in the prognosis of HCC.

语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学 4 区 病理学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学 4 区 病理学
JCR分区:
出版当年[2016]版:
Q3 PATHOLOGY Q4 ONCOLOGY
最新[2023]版:
Q3 PATHOLOGY Q4 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1]Affiliated Hosp Hebei Univ, Dept Hepatobiliary Surg, Baoding 071000, Hebei Province, Peoples R China
通讯作者:
通讯机构: [1]Affiliated Hosp Hebei Univ, Dept Hepatobiliary Surg, Baoding 071000, Hebei Province, Peoples R China [*1]Department of Hepatobiliary Surgery, Affiliated Hospital of Hebei University, Baoding 071000, Hebei Province, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:15100 今日访问量:0 总访问量:960 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北大学附属医院 技术支持:重庆聚合科技有限公司 地址:保定市莲池区裕华东路212号